The Study of [14C] GZR18

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
OverweightObeseObesity
Interventions
DRUG

GZR18 injection、[14C]GZR18 injection

Participants will get a single dose of \[14C\]GZR18 injection

Trial Locations (1)

Unknown

Study site 01, Beijing

Sponsors
All Listed Sponsors
lead

Gan & Lee Pharmaceuticals.

INDUSTRY

NCT07119450 - The Study of [14C] GZR18 | Biotech Hunter | Biotech Hunter